About IBRX Dividend Returns
ImmunityBio, Inc. (IBRX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of IBRX over the past year?
ImmunityBio, Inc. (IBRX) delivered a return of 197.26% over the past year. Since IBRX does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in IBRX be worth today?
A $10,000 investment in ImmunityBio, Inc. one year ago would be worth $29,726 today, representing a gain of $19,726.
Q3Does IBRX pay dividends?
ImmunityBio, Inc. (IBRX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For IBRX, the total return equals the price-only return.
Q4Did IBRX beat the S&P 500?
Yes, ImmunityBio, Inc. (IBRX) outperformed the S&P 500 by 181.81 percentage points over the past year. IBRX delivered a total return of 197.26%, compared to the S&P 500's 15.45%. This 181.81pp alpha means investors in IBRX earned more than a passive S&P 500 index fund.
Q5What is IBRX's worst drawdown?
ImmunityBio, Inc. (IBRX) experienced a maximum drawdown of -43.75% over the past year, declining from its peak on 2025-03-27 to its trough on 2025-05-07. The stock recovered to its prior peak by 2025-06-09. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is IBRX's long-term total return over 10, 20, or 30 years?
ImmunityBio, Inc. (IBRX) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is 42.2% (3.6% CAGR) — $10,000 would have grown to $14,215. Over 20 years: -71.8% total return (-6.1% CAGR) — $10,000 → $2,823. Over 30 years: -71.8% total return (-4.1% CAGR) — $10,000 → $2,823. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was IBRX's best and worst year?
ImmunityBio, Inc.'s best calendar year was 2020 with a total return of 236.6%. Its worst year was 2018 with a total return of -73.5%. This range shows the volatility investors should expect — the difference between the best and worst year is 310.1 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).